Fauci Intelligence Community Release — page 71
of 88 pages
← p.70 p.72 → · this page in the original PDF · package
UNCLASSIFIED
UNCLASSIFIED
When synthesized with the EcoHealth Alliance proposal, US collections
confirm EcoHealth Alliance was performing the work proposed. The analysts
produce their reports in a vacuum, absent the context the proposal
provides. As a fellow at DARPA, I could see both, and can do the
synthesis. For instance, WIV personnel identified in intelligence
reports are named in the proposal, these people use the lexicon of the
proposal in the collections, and the virus variants proposed for
experimentation are identical to those gleaned by collections. Moreover,
I am also privy to information obtained by congressional office
investigators and by DRASTICiv, which further corroborates that the
program detailed in the BAA response was conducted until it was shut
down in April 2020.
The purpose of the EcoHealth program, called DEFUSEv in the proposal,
was to inoculate bats in the Yunnan, China caves where confirmed SARSCoVs were found. Ostensibly, doing this would prevent another SARS-CoV
pandemic; the bats' immune systems would be reinforced to prevent a
deadly SARS-CoV from emerging. The specific language used is "inoculate
bats with novel chimeric polyvalent spike proteins to enhance their
adaptive immune memory against specific high-risk viruses." vi Being
defense-related, it makes sense that EcoHealth submitted the proposal
first to the Department of Defense, before it settled with NIH/NIAID.
The BAA response is dated March 2018 and was submitted by Peter Daszak,
president of EcoHealth Alliance.
DARPA rejected the proposal because the work was too close to violating
the gain-of-function (GoF) moratorium,vii despite what Peter Daszak says
in the proposal (that the work would notviii). As is known, Dr. Fauci with
NIAID did not reject the proposal. The work took place at the WIV and
at several sites in the US, identified in detail in the proposal.ix
The EcoHealth Alliance response to the PREEMPT BAA is placed along with
other proposal documents in the PREEMPT folder on the DARPA Biological
Technologies
Office
JWICS
(top
secret)
share
drive,
address:
Network/filer/BTO/CI Folder/PREEMPT
This folder was empty for a year. The files, completely unmarked with
classification or distribution data, were placed in this folder in July
2021, which conspicuously aligns with media reporting, my probing, and
Senator Paul's inquiry into NIH/NIAID gain-of-function programs. The
unmarked nature combined with the timing signals that the documents were
being hidden. No files at DARPA go unmarked in classification or
distribution, including proprietary documents. Furthermore, PREEMPT is
an unclassified program.
The files are also now held by Marine Corps Intelligence Activity (MCIA).
They are identified in the reference block above.
2. SARS-CoV-2, hereafter referred to as SARSr-CoV-WIV, is a synthetic
spike protein chimera engineered to attach to human ACE2 receptors and
For SHSGAC Use Only - SHSGAC_COVID_119th 011833
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/fauci_intel/71
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| fauci_intel:email:00051 | — | 70–72 |